| Financial Year |
March 31 2023 |
| Monetary Funds |
186,305,661,744.74 |
| Held-for-trading Financial Assets |
1,238,999,479.72 |
| Notes Receivable |
13,259,944.05 |
| Accounts Receivable |
17,367,184,068.95 |
| Advances to Suppliers |
2,407,498,871.19 |
| Other Receivables |
1,022,058,163.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
80,498.66 |
| Inventories |
40,540,365,977.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,451,424,730.01 |
| Other Current Assets |
2,613,348,783.56 |
| Total Current Assets |
277,381,491,330.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
115,026,516.42 |
| Long-term Equity Investment |
6,107,416,905.59 |
| Investment Properties |
625,920,217.40 |
| Fixed Assetes |
33,856,872,928.07 |
| Under-construction Projects |
6,304,528,014.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,541,289,251.23 |
| R&D expenses |
-- |
| Goodwill |
1,659,358,399.03 |
| Long-Term Deferred and Prepaid Expenses |
22,856,962.90 |
| Deferred Income Tax Assets |
15,055,351,075.62 |
| Other Non-Current Assets |
1,345,379,549.33 |
| Sub-Total of Non-Current Assets |
107,229,032,826.77 |
| Total Assets |
384,610,524,157.54 |
| Short-Term Loans |
54,059,888,808.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,484,764,479.66 |
| Accounts Payable |
35,496,412,331.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,831,428,962.19 |
| Taxes Payable |
3,115,744,266.41 |
| Interest Payable |
-- |
| Dividend Payable |
5,549,149.67 |
| Other payables |
6,316,355,200.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,291,817,780.74 |
| Other Current Liabilities |
59,987,802,797.18 |
| Sub-Total of Current Liabilities |
221,902,914,306.84 |
| Long-term Loans |
48,947,930,269.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
71,917,203.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,441,669,069.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
55,858,732,828.51 |
| Total Liabilities |
277,761,647,135.35 |
| Paid-In Capital(Or Share Stock) |
5,631,405,741.00 |
| Capital Surplus |
817,581,092.58 |
| Surplus Reserve |
3,745,823.71 |
| LESS:Treasury Stock |
3,086,056,308.71 |
| Undistributed Profits |
95,315,966,941.95 |
| Minority Stockholder's Interest |
4,907,338,647.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
101,941,538,374.25 |
| Owner's Equity（Stockholder's Equity） |
106,848,877,022.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
384,610,524,157.54 |
